Global Alexipharmic Drugs Market
Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region
March 12, 2024 13:46 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region" report has been added to ...
Global Substance Abuse Disorder Treatment Market
Global Substance Abuse Disorder Treatment Research Analysis Report 2024: Public and Private Entities Join Forces to Tackle Substance Abuse Epidemic - Forecasts to 2034
January 31, 2024 09:44 ET | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Substance Abuse Disorder Treatment Market Analysis & Forecast 2024-2034: Market By Treatment; By End-user; and By Region" report has been...
image003.png
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 14, 2023 07:30 ET | DMK Pharmaceuticals Corporation
Rebranded company to DMK Pharmaceuticals and appointed inaugural, passionate and committed leadership team to execute on new strategy to reduce opioid related deaths through enhanced sales of ZIMHI®...
image003.png
DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023
November 13, 2023 10:52 ET | DMK Pharmaceuticals Corporation
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
June 22, 2023 07:30 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that Eboo Versi, MD, PhD, CEO of Adamis...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
May 25, 2023 16:26 ET | Adamis Pharmaceuticals Corporation
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined companyCombined company will have commercial products and a library of development candidates, including two clinical...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 15, 2023 16:47 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company focused on developing and commercializing products in...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update
May 08, 2023 16:05 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
March 16, 2023 16:24 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company focused on developing and commercializing products in various therapeutic...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate Update
March 14, 2023 16:01 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing...